Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

Atherosclerosis - Tập 114 - Trang 93-103 - 1995
Andrew G. Bostom1, Douglas Shemin2, Kate L. Lapane3, Joshua W. Miller4, Patrice Sutherland1, Marie Nadeau4, Elias Seyoum4, Wilburta Hartman4, Ronald Prior4, Peter W.F. Wilson1, Jacob Selhub4
1The Framingham Heart Study, Epidemiology and Biometry Program, 5 Thurber Street, Framingham, MA 01701, USA
2Division of Renal Diseases, Rhode Island Hospital, Providence, RI, USA
3Division of Health Education, Memorial Hospital of Rhode Island, Pawtucket, RI, USA
4The USDA Human Nutrition Research Center on Aging, Tufts New England Medical Center, Boston, MA, USA

Tài liệu tham khảo

Majorca, 1993, Morbidity and mortality of CAPD and hemodialysis, Kidney Int, 43, S Parfrey, 1994, Long term cardiac morbidity and mortality during dialysis therapy, Adv Nephrol, 23, 311 Ma, 1992, Cardiovascular risk factors in chronic renal failure and hemodialysis populations, Am J Kidney Dis, 19, 505, 10.1016/S0272-6386(12)80827-4 Rostand, 1982, Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease, Kidney Int, 22, 304, 10.1038/ki.1982.170 Ueland, 1992, Plasma homocysteine and cardiovascular disease, 183 Stampfer, 1992, A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US, physicians, J Am Med Assoc, 268, 877, 10.1001/jama.1992.03490070059042 Wilcken, 1980, Accumulation of sulphur-containing amino acids including cysteine-homocysteine mixed disulfide in patients on maintenance haemodialysis, Clin Sci, 58, 427, 10.1042/cs0580427 Kang, 1983, Plasma protein-bound homocyst(e)ine in patients requiring chronic hemodialysis, Clin Sci, 65, 335, 10.1042/cs0650335 Chauveau, 1993, Hyperhomocyst(e)inemia, a risk factor for atherosclerosis in chronic uremic patients, Kidney Int, 43, S72 Hultberg, 1993, Plasma homocysteine in renal failure, Clin Nephrol, 40, 230 Ueland, 1989, Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy, J Lab Clin Med, 114, 473 Brosnan, 1986, The 1986 Borden Award Lecture. The role of the kidney in amino acid metabolism and nutrition, Can J Physiol Pharmacol, 65, 2355, 10.1139/y87-373 Tizianello, 1980, Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency, J Clin Invest, 65, 1162, 10.1172/JCI109771 Selhub, 1993, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, J Am Med Assoc, 270, 2693, 10.1001/jama.1993.03510220049033 Kannel, 1979, An investigation of coronary heart disease in families, Am J Epidemiol, 110, 281, 10.1093/oxfordjournals.aje.a112813 Willett, 1985, Reproducibility and validity of a semiquantitative food frequency questionnaire, Am J Epidemiol, 122, 51, 10.1093/oxfordjournals.aje.a114086 McNamara, 1987, Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions, Clin Chim Acta, 166, 1, 10.1016/0009-8981(87)90188-4 Warnick, 1982, Dextran sulfate-magnesium precipitation procedure for quantitation of high density lipoprotein cholesterol, Clin Chem, 28, 1379, 10.1093/clinchem/28.6.1379 Owen, 1993, The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis, N Engl J Med, 329, 1001, 10.1056/NEJM199309303291404 Nolph, 1992, Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis, ASAIO J, 38, M139, 10.1097/00002480-199207000-00004 Araki, 1987, Determination of free and total homocysteine in human plasma, by high performance liquid chromatography with fluorescence detection, J Chromatog, 422, 43, 10.1016/0378-4347(87)80438-3 Shin-Buering, 1981, A new enzymatic method for pyridoxal 5′-phosphate determination, J Inherit Metab Dis, 4, 123, 10.1007/BF02263621 Horne, 1988, Lactobacillus casei assay of folic acis derivatives in 96-well microtiter plates, Clin Chem, 34, 2357, 10.1093/clinchem/34.11.2357 Genest, 1990, Plasma homocyst(e)ine levels in men with premature coronary artery disease, J Am Coll Cardiol, 16, 1114, 10.1016/0735-1097(90)90542-W 1993, Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), J Am Med Assoc, 269, 3015, 10.1001/jama.1993.03500230097036 Hosmer, 1989, Applied Logistic Regression, 127 1990 Wu, 1993, Cardiovascular deaths among CAPD patients, Perit Dial Bull, 4, S Hennekens, 1986, Epidemiology in Medicine, 169 Dudman, 1991, Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine, Atherosclerosis, 91, 77, 10.1016/0021-9150(91)90189-A Wang, 1993, Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells, Thromb Haemotol, 70, 1047 Dudman, 1993, Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis, Arterioscl Thromb, 13, 512, 10.1161/01.ATV.13.4.512 Tsai, 1994, Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis, 91, 6369 Mudd, 1985, The natural history of homocystinuria due to cystathionine beta synthase deficiency, Am J Hum Genet, 37, 1 Minkhorst, 1991, Cerebral infarction after ceasarean section due to heterozygosity for homocystinuria: a case report, Eur J Obstet Gynecol Reprod Biol, 40, 241, 10.1016/0028-2243(91)90126-6 Dudman, 1987, Homocysteinemia: depressed plasma serine levels, Metabolism, 36, 198, 10.1016/0026-0495(87)90018-7 Wilcken, 1988, Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease, Metabolism, 37, 697, 10.1016/0026-0495(88)90093-5 Wilcken, 1981, Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism, Clin Sci, 61, 743, 10.1042/cs0610743 Arnadottir, 1993, The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients, Clin Nephrol, 40, 236 Dunn, 1966, Homocystinuria: a recently discovered cause of mental defect and cerebrovascular thrombosis, Neurology, 16, 407, 10.1212/WNL.16.4.407 Brattstrom, 1992, Hyperhomocysteinemia in stroke: prevalence, cause and relationships to type of stroke and stroke risk factors, Eur J Clin Invest, 22, 214, 10.1111/j.1365-2362.1992.tb01829.x Mudd, 1975, Labile methyl balances for normal humans on various dietary regimens, Metabolism, 24, 721, 10.1016/0026-0495(75)90040-2 Brattstrom, 1990, Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment, Atherosclerosis, 81, 51, 10.1016/0021-9150(90)90058-Q Miller, 1994, Vitamin B-6 deficiency vs. folate deficiency: comparison of responses to methionine loading in rats, Am J Clin Nutr, 59, 1033, 10.1093/ajcn/59.5.1033 Descombes, 1993, Water soluble vitamins in chronic hemodialysis patients and need for supplementation, Kidney Int, 43, 1319, 10.1038/ki.1993.185 Janssen, 1993, Folic acid lowers elevated homocysteine levels in chronic dialysis patients, J Am Soc Nephr, 4, 250 Guldener, 1994, Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients [abstract], Perit Dial Int, 14, S